Cascade Investment Group, Inc. Bristol Myers Squibb CO Transaction History
Cascade Investment Group, Inc.
- $151 Billion
- Q3 2025
A detailed history of Cascade Investment Group, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cascade Investment Group, Inc. holds 5,964 shares of BMY stock, worth $258,777. This represents 0.18% of its overall portfolio holdings.
Number of Shares
5,964
Previous 6,114
2.45%
Holding current value
$258,777
Previous $283 Million
4.96%
% of portfolio
0.18%
Previous 0.2%
Shares
5 transactions
Others Institutions Holding BMY
# of Institutions
2,668Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.3M-
Vanguard Group Inc Valley Forge, PA195MShares$8.46 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$6.88 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.69 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.11 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.07 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $92.3B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...